The disposable endoscope market is expected to reach a

0

NEWARK, Del, Sep 02, 2022 (GLOBE NEWSWIRE) — According to the latest analysis by Future Market Insights, the valuation of the global disposable endoscope market was around $909.9 min in 2021. The market is expected to grow at a CAGR of nearly 17.6% from 2022 to 2032 and reach an estimated valuation of around $5.3 Bn in 2032.

Endoscope-related infections can be differentiated into endogenous and exogenous. The presence of microbes capable of forming biofilms or adhering to medical devices may have the ability to cause cross-contamination in healthcare facilities. Therefore, disposable endoscopes are a better option that allows healthcare facilities to skip reprocessing steps and also reduce the risk of acquiring infections. Between 2019 and 2020, in the United States, there was a 24% increase in central line-associated bloodstream infections (CLABSI), with the largest increase seen in ICUs (50%), according to the Centers for Disease Control and Prevention (CDC).

Growing investments in research and development activities and healthcare institutions to develop new products with emphasis on low cost product offerings and less infection exposure, is also expected to propel the disposable endoscope market during the forecast period. Emerging startups are focusing on improving the functionality of endoscopes to attract more customers.

Get sample PDF report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15535

The use of ultra-fine polymer fibers makes it possible to reach previously inaccessible anatomical sites. Increase in the preference of doctors and patients for the detection of cancer and tumors and reduction in the risk of infection due to the safety and efficiency of endoscopic procedures would also promote the growth of the disposable endoscopes market.

In August 2021, for example, a personalized pilgrim endoscope from 3NT was launched to provide clinicians with a close-up view of hard-to-reach regions with sinuses to aid in the diagnosis and treatment of conditions, including polyps and cancer.

Key points to remember: disposable endoscopes market

  • Disposable bronchoscopes are the main product type and have a capacity of approximately 30.1% of the global market share in 2021.
  • By end-user, hospitals dominate the global disposable endoscope market and are expected to show a CAGR of 17.5% during the forecast period.
  • China is one of the leading manufacturers of disposable endoscopes and it held a market share of around 6.7% in 2021.
  • Germany posted a share of around 7.5% in the European disposable endoscope market in 2021.
  • North America is considered the top region and holds a share of 36.8% in 2021.

“The growing focus on technological advancements and the development of cost-effective disposable medical equipment is expected to propel disposable endoscope sales across the globe,” says an analyst from Future Market Insights.

Talk to analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15535

Competitive Landscape: Disposable Endoscopes Market

The disposable endoscope market is highly fragmented with the presence of several local, emerging and established players. Major players are focusing on launching new products with added features, securing regulatory approvals and increasing their manufacturing capacities to compete with their rivals.

For instance,

  • In April 2022Ambu has launched a single-use endoscope accompanied by an mA oscilloscope, known as the Ascope 4 Rhinolaryngo Slim and Aview 2 Advance HD monitor, which would allow fiber optic endoscopic assessment of swallowing.
  • In May 2021Boston Scientific Corporation has obtained CE approval for its EXALT B model. It is a single-use bronchoscope, a device designed for bedside operations in the ICU and operating room.

Key players:

  • Ambu A/S
  • olympus america
  • Boston Scientific Society
  • Fujifilm Holding Corporation
  • NeoScope Inc.
  • Coloplast Corp.
  • Endotherapy Pty Ltd
  • Laborie
  • Shenzhen Tianlang Medical
  • Intersurgical
  • Incorporated Teleflex.
  • Bell Medical Inc.
  • PENTAX Medical
  • Cooper Surgical Inc.
  • Meditrina, Inc.
  • UroViu Company
  • Adler MicroMed, Inc.
  • Advin Health Care
  • BRAND KARL STORZ

Get more valuable insights into the Disposable Endoscopes Market

Future Market Insights offers a unique perspective and actionable insights into the Disposable Endoscopes market in its latest study, presenting historical demand assessment from 2012 to 2021 and projections for 2022 to 2032. The global Disposable Endoscopes market is segmented into detail to cover all aspects of the market and presents a comprehensive approach to market intelligence to the reader.

The research study is based on the products (disposable bronchoscopes, disposable cystoscopes, disposable duodenoscopes, disposable esophagoscopes, disposable hysteroscopes, disposable laryngoscopes, disposable proctoscopes and disposable ureteroscopes) and the end user (hospitals, ambulatory surgery center and center of diagnosis), across seven key regions of the world.

Buy this report now @ https://www.futuremarketinsights.com/checkout/15535

Contents
1. Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-side trends

1.4. Analysis and recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limits

2.3. Inclusions and exclusions

3. Key Market Trends

3.1. Key trends impacting the market

3.2. Product Innovation / Development Trends

Get a detailed table of contents @ https://www.futuremarketinsights.com/toc/rep-gb-15535

See related research reports from Health care

Flexible Endoscopes Market Size: The global flexible endoscopes market is expected to grow at a CAGR of 6.8% and reach US$11.75 billion by 2032 from US$5.7 billion in 2021.

Cell Therapy Manufacturing Market Forecast: The global cell therapy manufacturing market size is expected to reach a valuation of US$3.7 billion by the end of 2022 and expand further at a CAGR of 14.2% from 2022 to 2032.

Specialty Generics Market Snapshot: The global specialty generics market is expected to enjoy a valuation of US$61.8 billion by the end of 2022, and continue to grow at a CAGR of 7.7 % to reach a valuation of ~US$130.5 billion in 2032.

Pressure Ulcer Treatment Products Market Growth: The global demand for pressure ulcer treatment products is expected to be valued at US$4,283.3 million in 2022, and is expected to grow at a CAGR of 3.8% for be valued at US$6,219.4 million from 2022 to 2032.

Wearable Medical Devices Market Analysis: The global wearable medical devices market is expected to reach a valuation of US$27.29 billion by 2022, accelerating with a moderate CAGR of 28.1% through 2032.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR certified business consulting and market research firm, member of the Greater New York Chamber of Commerce and headquartered in Delaware, USA. Recipient of the 2022 Clutch Leaders Award for high customer score (4.9/5), we have partnered with global companies on their business transformation journey and helped them achieve their business ambitions. 80% of the Forbes 1000 largest companies are our clients. We serve global clients across all leading and niche market segments in all major industries.

Contact We:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Such. : +1-845-579-5705
For sales inquiries: [email protected]
Browse the latest market reports: https://www.futuremarketinsights.com/reports

Share.

About Author

Comments are closed.